Combination of Chemoradiation Therapy and Epitope Peptide Vaccine Therapy in Treating Patients With Esophageal Cancer

NCT00632333 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer

Interventions

BIOLOGICAL: URLC10, TTK, KOC1, VEGFR1, VEGFR2, cisplatin, fluorouracil

Sponsor

Teikyo University

Collaborators

[object Object]